{"transactions":[{"id":702315,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-07-29T01:00:34.000Z","date":"2026-07-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":3177,"price":8.37,"value":26591.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon the non-reportable vesting and settlement of restricted stock units (\"RSUs\"). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date, (i) 91,631 unvested RSUs out of 91,631 RSUs granted on February 9, 2026, vesting 25% on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 58,338 unvested RSUs out of 77,784 RSUs granted on February 19, 2025, vesting 25% on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 96,160 unvested RSUs out of 192,320 RSUs granted on April 1, 2024, vesting 25% on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 7,500 unvested RSUs out of 30,000 RSUs granted on July 24, 2023, vesting 25% on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (v) 23,750 unvested RSUs out of 95,000 RSUs granted on March 6, 2023, vesting 25% on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; and (vi) 165,682 shares of common stock directly owned by the Reporting Person, which reflects prior option exercises and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes. Each RSU represents a contingent right to receive one share of common stock of the Issuer."}],"balance_after":443061,"source":{"system":"sec-edgar","filing":"0001140361-26-029923","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126029923/form4.xml","form_type":"4"}},{"id":817024,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-04-04T01:00:32.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":20362,"price":9.11,"value":185497.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 91,631 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 58,338 unvested RSUs out of 77,784 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 96,160 unvested RSUs out of 192,320 RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 15,000 unvested RSUs out of 30,000 RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; (v) 23,750 unvested RSUs out of 95,000 RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; and (vi) 161,359 shares of common stock directly owned by the Reporting Person, which reflects prior option exercises and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":446238,"source":{"system":"sec-edgar","filing":"0001140361-26-013206","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126013206/form4.xml","form_type":"4"}},{"id":851457,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":2175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The incentive stock options were granted to the Reporting Person on July 19, 2021, and are fully vested."}],"balance_after":2825,"derivative":{"exercise_price":1.55,"expiration_date":"2031-07-19","underlying":"Common Stock","underlying_shares":2175},"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851456,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":1525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The incentive stock options were granted to the Reporting Person on February 25, 2021, and are fully vested."}],"balance_after":2225,"derivative":{"exercise_price":2.35,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":1525},"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851455,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":2646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The incentive stock options were granted to the Reporting Person on August 19, 2020, and are fully vested."}],"balance_after":2771,"derivative":{"exercise_price":2.83,"expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":2646},"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851454,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The incentive stock options were granted to the Reporting Person on June 5, 2019, and are fully vested."}],"balance_after":1250,"derivative":{"exercise_price":4.31,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851453,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The incentive stock options were granted to the Reporting Person on February 14, 2017, and are fully vested."}],"balance_after":2500,"derivative":{"exercise_price":5,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851452,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":10096,"price":15.63,"value":157800.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The securities were sold by the Reporting Person in accordance with the terms of the Divorce Settlement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.59 to $15.65, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes, as of the transaction date (i) 91,631 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 58,338 unvested RSUs out of 77,784 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 144,240 unvested RSUs out of 192,320 RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"(continued from footnote 5) (iv) 15,000 unvested RSUs out of 30,000 RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; (v) 23,750 unvested RSUs out of 95,000 RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; and (vi) 133,641 shares of common stock directly owned by the Reporting Person, which reflects prior option exercises and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":466600,"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851451,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":2175,"price":1.55,"value":3371.25,"ownership":{"direct":true},"balance_after":476696,"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851450,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":1525,"price":2.35,"value":3583.75,"ownership":{"direct":true},"balance_after":474521,"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851449,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":2646,"price":2.83,"value":7488.18,"ownership":{"direct":true},"balance_after":472996,"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851448,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":1250,"price":4.31,"value":5387.5,"ownership":{"direct":true},"balance_after":470350,"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851447,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":5,"value":12500.0,"ownership":{"direct":true},"balance_after":469100,"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851446,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-09","kind":"other","planned":false,"acquired":false,"shares":91266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were transferred by the reporting person in accordance with the terms of a court-approved divorce settlement agreement (the \"Divorce Settlement\")."}],"balance_after":466600,"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851445,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":4235,"price":15.39,"value":65176.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."}],"balance_after":557866,"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":851444,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-03-11T01:00:23.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":10059,"price":15.39,"value":154808.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."}],"balance_after":562101,"source":{"system":"sec-edgar","filing":"0001140361-26-008905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126008905/form4.xml","form_type":"4"}},{"id":888347,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-02-24T02:00:19.000Z","date":"2026-02-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":8161,"price":16.32,"value":133187.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 91,631 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 58,338 unvested RSUs out of 77,784 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 144,240 unvested RSUs out of 192,320 RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 15,000 unvested RSUs out of 30,000 RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; (v) 47,500 unvested RSUs out of 95,000 RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; (vi) 10,000 unvested RSUs out of 40,000 RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"(continued from footnote 3) and (vii) 205,451 shares of common stock directly owned by the Reporting Person, which reflects prior option exercises and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":572160,"source":{"system":"sec-edgar","filing":"0001140361-26-006462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126006462/form4.xml","form_type":"4"}},{"id":910201,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-12T02:00:20.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":144230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest over four years with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 9, 2030 in accordance with the Plan."}],"balance_after":144230,"derivative":{"exercise_price":16.37,"expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":144230},"source":{"system":"sec-edgar","filing":"0001140361-26-004891","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126004891/form4.xml","form_type":"4"}},{"id":910200,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2026-02-12T02:00:20.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":91631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest quarterly on each annual anniversary of the date of grant over four years in accordance with the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the \"Plan\"), subject to the Reporting Person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 91,631 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 77,784 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 144,240 unvested RSUs out of 192,320 RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 15,000 unvested RSUs out of 30,000 RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; (v) 47,500 unvested RSUs out of 95,000 RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date; (vi) 10,000 unvested RSUs out of 40,000 RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"(continued from footnote 3) and (vii) 194,166 shares of common stock directly owned by the Reporting Person, which reflects prior option exercises and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":580321,"source":{"system":"sec-edgar","filing":"0001140361-26-004891","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036126004891/form4.xml","form_type":"4"}},{"id":1077730,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-02T01:00:21.000Z","date":"2025-07-30","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on July 30, 2015 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.98,"expiration_date":"2025-07-30","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001140361-25-028449","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125028449/form4.xml","form_type":"4"}},{"id":1077729,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-08-02T01:00:21.000Z","date":"2025-07-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":1208,"price":18.59,"value":22456.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements and payment by the Reporting Person of the option exercise price. This is not an open market sale of securities. This option was automatically exercised on the expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 77,784 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 144,240 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 15,000 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 47,500 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 10,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 194,166 shares of common stock directly owned by the reporting person, which includes the option exercise described in footnote 1 and prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":488690,"source":{"system":"sec-edgar","filing":"0001140361-25-028449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125028449/form4.xml","form_type":"4"}},{"id":1077728,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-08-02T01:00:21.000Z","date":"2025-07-30","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":8.98,"value":22450.0,"ownership":{"direct":true},"balance_after":489898,"source":{"system":"sec-edgar","filing":"0001140361-25-028449","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125028449/form4.xml","form_type":"4"}},{"id":1080769,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-07-29T01:02:55.000Z","date":"2025-07-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":3027,"price":17.31,"value":52397.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 77,784 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 144,240 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 15,000 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 47,500 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 10,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 192,874 shares of common stock directly owned by the reporting person, which includes the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":487398,"source":{"system":"sec-edgar","filing":"0001140361-25-027642","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125027642/form4.xml","form_type":"4"}},{"id":1184028,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-04-03T01:00:38.000Z","date":"2025-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":18920,"price":19.42,"value":367426.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 77,784 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 144,240 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 47,500 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 10,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 188,401 shares of common stock directly owned by the reporting person, which includes the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":490425,"source":{"system":"sec-edgar","filing":"0001140361-25-011931","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125011931/form4.xml","form_type":"4"}},{"id":1215482,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-03-11T01:00:14.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":3935,"price":17.02,"value":66973.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes, as of the transaction date (i) 77,784 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"(continued from footnote 4) (iv) 47,500 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 10,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 159,241 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":509345,"source":{"system":"sec-edgar","filing":"0001140361-25-007923","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125007923/form4.xml","form_type":"4"}},{"id":1215481,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-03-11T01:00:14.000Z","date":"2025-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":8881,"price":16.91,"value":150177.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 77,784 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iv) 47,500 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) the reporting person's continued service as of the applicable vesting date; (v) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 153,176 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":513280,"source":{"system":"sec-edgar","filing":"0001140361-25-007923","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125007923/form4.xml","form_type":"4"}},{"id":1241152,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-02-28T02:00:22.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1855,"price":15.44,"value":28641.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 77,784 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iv) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (v) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 138,307 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":522161,"source":{"system":"sec-edgar","filing":"0001140361-25-006385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125006385/form4.xml","form_type":"4"}},{"id":1253409,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-22T02:01:54.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":116279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest over four years with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 19, 2029 in accordance with the Plan."}],"balance_after":116279,"derivative":{"exercise_price":16.07,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":116279},"source":{"system":"sec-edgar","filing":"0001140361-25-005535","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125005535/form4.xml","form_type":"4"}},{"id":1253408,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-02-22T02:01:54.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":77784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") that will vest quarterly on each annual anniversary of the date of grant over four years in accordance with the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the \"Plan\"), subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 77,784 unvested RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iv) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (v) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (vi) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vii) 135,162 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":524016,"source":{"system":"sec-edgar","filing":"0001140361-25-005535","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125005535/form4.xml","form_type":"4"}},{"id":1287608,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-04T02:00:15.000Z","date":"2025-01-30","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on January 30, 2015 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.8,"expiration_date":"2025-01-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-25-002926","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125002926/form4.xml","form_type":"4"}},{"id":1287607,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-02-04T02:00:15.000Z","date":"2025-01-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3355,"price":16.1,"value":54015.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements and payment by the Reporting Person of the option exercise price. This is not an open market sale of securities. This option was automatically exercised on the expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 135,162 shares of common stock owned by the reporting person, which reflects the option exercise described in footnote 1 and prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":446232,"source":{"system":"sec-edgar","filing":"0001140361-25-002926","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125002926/form4.xml","form_type":"4"}},{"id":1287606,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-02-04T02:00:15.000Z","date":"2025-01-30","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":10.8,"value":54000.0,"ownership":{"direct":true},"balance_after":449587,"source":{"system":"sec-edgar","filing":"0001140361-25-002926","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125002926/form4.xml","form_type":"4"}},{"id":1315583,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2025-01-04T02:00:31.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1854,"price":17.15,"value":31796.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (\"RSUs\"). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 133,517 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":444587,"source":{"system":"sec-edgar","filing":"0001140361-25-000271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036125000271/form4.xml","form_type":"4"}},{"id":1394869,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-10-03T01:00:38.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2647,"price":19.99,"value":52913.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (RSUs). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 6,250 unvested RSUs granted on September 28, 2021, which are the remaining unvested RSUs of the 100,000 RSUs granted on September 28, 2021 which vest on a schedule of 50% vesting on December 31, 2022 and the remaining vesting quarterly from March 31, 2023 to December 31, 2024, subject to the reporting person's continued service as of the applicable vesting date; (vi) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"(continued from footnote 3) (vii) 129,121 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":446441,"source":{"system":"sec-edgar","filing":"0001140361-24-042642","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124042642/form4.xml","form_type":"4"}},{"id":1419116,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-08-31T01:05:28.000Z","date":"2024-08-30","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":4.72,"value":23600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options were granted on May 3, 2018 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.72,"expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-24-039822","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124039822/form4.xml","form_type":"4"}},{"id":1419115,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-08-31T01:05:28.000Z","date":"2024-08-30","kind":"exercise","planned":false,"acquired":false,"shares":6650,"price":5.94,"value":39501.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options were granted on October 9, 2018 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.94,"expiration_date":"2028-10-09","underlying":"Common Stock","underlying_shares":6650},"source":{"system":"sec-edgar","filing":"0001140361-24-039822","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124039822/form4.xml","form_type":"4"}},{"id":1419114,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-08-31T01:05:28.000Z","date":"2024-08-30","kind":"exercise","planned":false,"acquired":false,"shares":4375,"price":2.59,"value":11331.25,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options were granted on March 10, 2020 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.59,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":4375},"source":{"system":"sec-edgar","filing":"0001140361-24-039822","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124039822/form4.xml","form_type":"4"}},{"id":1419113,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-08-31T01:05:28.000Z","date":"2024-08-30","kind":"exercise","planned":false,"acquired":false,"shares":8125,"price":2.35,"value":19093.75,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on February 25, 2021 and will vest over four years with 25% of the shares of common stock underlying the options vesting on the one-year anniversary of the date of grant and the remaining 75% of such shares vesting monthly in equal installments over the next three years thereafter, subject to the reporting person's continued service as of the applicable vesting date, and will become fully vested on February 25, 2025."}],"balance_after":3750,"derivative":{"exercise_price":2.35,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001140361-24-039822","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124039822/form4.xml","form_type":"4"}},{"id":1419112,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-08-31T01:05:28.000Z","date":"2024-08-30","kind":"sale","planned":false,"acquired":false,"shares":24150,"price":16.8965,"value":408050.475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $16.72 to $17.02. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) the reporting person's continued service as of the applicable vesting date; (v) 12,500 unvested RSUs granted on September 28, 2021, which are the remaining unvested RSUs of the 100,000 RSUs granted on September 28, 2021 which vest on a schedule of 50% vesting on December 31, 2022 and the remaining vesting quarterly from March 31, 2023 to December 31, 2024, subject to the reporting person's continued service as of the applicable vesting date; (vi) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vii) 125,518 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":449088,"source":{"system":"sec-edgar","filing":"0001140361-24-039822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124039822/form4.xml","form_type":"4"}},{"id":1419111,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-08-31T01:05:28.000Z","date":"2024-08-30","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":4.72,"value":23600.0,"ownership":{"direct":true},"balance_after":473238,"source":{"system":"sec-edgar","filing":"0001140361-24-039822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124039822/form4.xml","form_type":"4"}},{"id":1419110,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-08-31T01:05:28.000Z","date":"2024-08-30","kind":"exercise","planned":false,"acquired":true,"shares":6650,"price":5.94,"value":39501.0,"ownership":{"direct":true},"balance_after":468238,"source":{"system":"sec-edgar","filing":"0001140361-24-039822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124039822/form4.xml","form_type":"4"}},{"id":1419109,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-08-31T01:05:28.000Z","date":"2024-08-30","kind":"exercise","planned":false,"acquired":true,"shares":4375,"price":2.59,"value":11331.25,"ownership":{"direct":true},"balance_after":461588,"source":{"system":"sec-edgar","filing":"0001140361-24-039822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124039822/form4.xml","form_type":"4"}},{"id":1419108,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-08-31T01:05:28.000Z","date":"2024-08-30","kind":"exercise","planned":false,"acquired":true,"shares":8125,"price":2.35,"value":19093.75,"ownership":{"direct":true},"balance_after":457213,"source":{"system":"sec-edgar","filing":"0001140361-24-039822","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124039822/form4.xml","form_type":"4"}},{"id":1448197,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-07-27T01:10:31.000Z","date":"2024-07-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2502,"price":13.58,"value":33977.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (RSUs). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 12,500 unvested RSUs granted on September 28, 2021, which are the remaining unvested RSUs of the 100,000 RSUs granted on September 28, 2021 which vest on a schedule of 50% vesting on December 31, 2022 and the remaining vesting quarterly from March 31, 2023 to December 31, 2024, subject to the reporting person's continued service as of the applicable vesting date; (vi) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"(continued from footnote 3) and (vii) 125,518 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":449088,"source":{"system":"sec-edgar","filing":"0001140361-24-034472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124034472/form4.xml","form_type":"4"}},{"id":1463546,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-07-03T01:01:54.000Z","date":"2024-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2085,"price":11.18,"value":23310.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (RSUs). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 30,000 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continued from footnote 2) (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 12,500 unvested RSUs granted on September 28, 2021, which are the remaining unvested RSUs of the 100,000 RSUs granted on September 28, 2021 which vest on a schedule of 50% vesting on December 31, 2022 and the remaining vesting quarterly from March 31, 2023 to December 31, 2024, subject to the reporting person's continued service as of the applicable vesting date; (vi) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"(continued from footnote 3) and (vii) 120,520 shares of common stock owned by the reporting person, which reflects the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes."}],"balance_after":451590,"source":{"system":"sec-edgar","filing":"0001140361-24-032247","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124032247/form4.xml","form_type":"4"}},{"id":1554103,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-03T01:01:37.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":300328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests over four years with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on the four-year anniversary of the grant date."}],"balance_after":300328,"derivative":{"exercise_price":6.54,"expiration_date":"2034-04-01","underlying":"Common Stock","underlying_shares":300328},"source":{"system":"sec-edgar","filing":"0001140361-24-017377","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124017377/form4.xml","form_type":"4"}},{"id":1554102,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-04-03T01:01:37.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":192320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares represent RSUs that will vest in four equal installments (25% per installment) on each annual anniversary of the date of grant over four years, in each case under the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the \"Plan\") subject to the reporting person's continued service as of the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes, as of the transaction date, (i) 192,320 RSUs granted on April 1, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (3); and (ii) 112,190 shares acquired pursuant to the vesting of RSUs."}],"balance_after":304510,"source":{"system":"sec-edgar","filing":"0001140361-24-017377","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124017377/form4.xml","form_type":"4"}},{"id":1554101,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":28295,"kind":"person","name":"Kestenberg-Messina Kaitlin M.","position":1,"cik":"0002017423","reported_name":"Kestenberg-Messina Kaitlin M.","relationship":{"officer":true,"officer_title":"COO and SVP, Compliance"}}],"security":"Common Stock","published_at":"2024-04-03T01:01:37.000Z","date":"2024-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2085,"price":6.6,"value":13761.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (RSUs). This is not an open market sale of securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"As of the transaction date, represents 112,190 shares of Common Stock acquired pursuant to the vesting of RSUs."}],"balance_after":112190,"source":{"system":"sec-edgar","filing":"0001140361-24-017377","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017423/000114036124017377/form4.xml","form_type":"4"}}]}